Semaglutide Nasal 15mg
$134.99
Semaglutide Nasal (15mg) is a non-invasive GLP-1 receptor agonist formulation studied for its potential effects on appetite regulation, glucose metabolism, and weight loss. Designed for convenient delivery in preclinical research models.
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.
Description
Semaglutide Nasal Spray (15mg) delivers a long-acting GLP-1 receptor agonist through a convenient intranasal route, allowing for non-invasive administration in preclinical metabolic studies. Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), studied extensively for its role in regulating appetite, enhancing insulin sensitivity, and promoting weight loss.
Unlike injectable forms, the nasal spray allows for rapid absorption and simplified dosing without needles—making it ideal for frequent, repeatable protocols in laboratory settings. It activates central and peripheral GLP-1 pathways to influence metabolic and neuroendocrine responses.
How Semaglutide Nasal Works (Based on Preclinical Research):
-
Stimulates GLP-1 receptors to promote glucose-dependent insulin secretion
-
Acts on the hypothalamus to reduce appetite and increase satiety
-
Slows gastric emptying and supports improved postprandial glucose control
-
Nasal absorption bypasses first-pass metabolism for direct systemic delivery
Potential Benefits (Based on Preclinical Research):
-
Reduced food intake and body weight in metabolic models
-
Improved glycemic control and insulin regulation
-
Convenient, non-invasive delivery method
-
Supports research into obesity, type 2 diabetes, and appetite disorders
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.
Reviews
There are no reviews yet.